1B

Results: 5852



#Item
71

julvegecover&13&09&1b.indd

Add to Reading List

Source URL: www.taty.be

- Date: 2016-11-15 23:04:51
    72

    Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

    Add to Reading List

    Source URL: s3.amazonaws.com

    - Date: 2014-09-25 16:16:58
      73

      ucsc_color_map_master_12-12_v11-1b

      Add to Reading List

      Source URL: maps.ucsc.edu

      - Date: 2016-11-18 17:49:22
        74

        A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer Dose Level – mg/kg Median age (years)

        Add to Reading List

        Source URL: posters.omed.s3.amazonaws.com

        - Date: 2016-01-22 10:42:40
          75

          Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Wells Messersmith,1

          Add to Reading List

          Source URL: publications.oncomed.com

          - Date: 2016-10-08 04:07:44
            76

            A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer 1Hidalgo Patient Demographics (n=47) DEM + GEM

            Add to Reading List

            Source URL: s3.amazonaws.com

            - Date: 2014-09-25 16:14:56
              77

              Final Results of a Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Study E

              Add to Reading List

              Source URL: s3.amazonaws.com

              - Date: 2015-01-16 14:31:43
                78

                Recommendations: Hemodynamic Support and Adjunctive Therapy* G. Fluid Therapy of Severe Sepsis 1. Crystalloids as the initial fluid of choice in the resuscitation of severe sepsis and septic shock (grade 1B). 2. Against

                Add to Reading List

                Source URL: www.survivingsepsis.org

                - Date: 2013-01-11 12:36:03
                  79

                  Elsevier_W_Research_Information_1b_aw

                  Add to Reading List

                  Source URL: www.americalatina.elsevier.com

                  - Date: 2015-03-13 08:21:03
                    80

                    Microsoft Word - New General Terms and Conditions ENG ver 1.1b.DOC

                    Add to Reading List

                    Source URL: www.historymuseum.ca

                    - Date: 2015-10-01 07:36:43
                      UPDATE